The global idiopathic pulmonary fibrosis treatment market grew at a CAGR of around 12% during 2014-2019.
Idiopathic pulmonary fibrosis (IPF) refers to a progressive and irreversible fibrosing interstitial pneumonia that directly impacts the functioning of the lungs. It is characterized by the formation of scar tissue within the lungs that starts at the edges and progresses toward the center, thus causing difficulties in breathing and insufficient delivery of oxygen to the body parts. It is diagnosed through chest imaging studies, lung biopsies, pulmonary function tests and antibody tests. Two of the most commonly used antifibrotic therapy includes nintedanib and pirfenidone-based drugs, which improves lung functioning and minimizes the risks of acute respiratory deterioration. They are often coupled with oxygen therapy and palliative care to provide comfort and improve the recovery of the patient.
The increasing prevalence of fibrotic diseases, along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Furthermore, changing lifestyle patterns and increasing consumption of nicotine products, such as cigarettes, is providing a thrust to the market growth. Moreover, smoking tobacco and cigarettes is considered as one of the most common causes for the development of IPF. In line with this, increasing health consciousness among the masses regarding the effective management strategies of IPF is also favoring the growth of the market. Additionally, the advent of novel medicines and advancements in the IPF diagnostic and treatment methods, are acting as other growth-inducing factors. This, along with extensive research and development (R&D) activities and improvements in the healthcare infrastructure, represents some of the other factors anticipated to drive the market further. Looking forward, the analyst expects the global idiopathic pulmonary fibrosis treatment market to continue its strong growth during the next five years.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global idiopathic pulmonary fibrosis treatment market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, drug class and end user.
Breakup by Drug Class: MAPK Inhibitors Tyrosine Inhibitors Autotaxin Inhibitors
Breakup by End User: Hospitals Long-term Care Facilities Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being AdAlta Pty Ltd., Angion Biomedica Corp., Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG), Bristol-Myers Squibb Company, Cipla Inc., F. Hoffmann-La Roche AG (Roche Holding AG), Fibrogen Inc., Galapagos NV, Liminal BioSciences Inc., Medicinova Inc., Merck & Co. Inc., Novartis AG and Vectura Group Plc.
Key Questions Answered in This Report: How has the global idiopathic pulmonary fibrosis treatment market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global idiopathic pulmonary fibrosis treatment market? What are the key regional markets? What is the breakup of the market based on the drug class? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global idiopathic pulmonary fibrosis treatment market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
376 pages •
By Global Industry Analysts
• Oct 2020
As the World’s Population Ages, New Healthcare Challenges Will Need to Be Managed With Great Planning & Care to Avert a Social Crisis. Disabled & Elderly Assistive Technology to Reach $34 Billion The global market for Disabled & Elderly Assistive Technology is projected to reach US$34 billion by the year 2027, trailing a post COVID-19...
Report Scope: This report examines the current and projected market potential of elder care services and assistive devices.It offers a detailed analysis of the competitive environment, market background, technological advancement, drivers, restraints and market growth trends. The report also includes market projections...
129 pages •
By Global Industry Analysts
• Sep 2020
Global Left Ventricular Assist Device (LVAD) Market to Reach $2.2 Billion by 2027 Amid the COVID-19 crisis, the global market for Left Ventricular Assist Device (LVAD) estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 9.1% over the analysis period 2020-2027....
The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare...
Mechanical Circulatory Support Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Mechanical Circulatory Support Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Mechanical Circulatory Support Devices pipeline...
Geriatric Care Services Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Geriatric Care Services market including the COVID-19 pandemic implications...
Medical Lifting Sling Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Medical Lifting Sling market including the COVID-19 pandemic implications...
Patient Temperature Management Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Patient Temperature Management market including the COVID-19...
304 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Sep 2020
A recent market study published on the Patient Identification Wristbands market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the...
120 pages •
By Infiniti Research Limited
• Sep 2020
Global Gait Biometrics Market 2020-2024 The analyst has been monitoring the gait biometrics market and it is poised to grow by $ 30.95 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on gait biometrics market provides a holistic analysis, market size and forecast, trends, growth drivers,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.